Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.2000 (-4.73%) ($30.1800 - $31.6400) on Tue. Jul. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.76% (three month average) | RSI | 30 | Latest Price | $30.2000(-4.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(58%) ARKG(56%) IBUY(54%) IWC(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.38% in a week (0% probabilities). VIXM(-28%) UUP(-15%) VXX(-12%) TBT(-7%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.38% (StdDev 4.76%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
1 - 5 Day Possible Target | $21.89(-27.52%) | Resistance Level | $31.54 | 5 Day Moving Average | $30.46(-0.85%) | 10 Day Moving Average | $31.18(-3.14%) | 20 Day Moving Average | $31.54(-4.25%) | To recent high | -12.8% | To recent low | 36% | Market Cap | $1.876b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |